SAN RAMON, Calif., July 13, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 11, 2022, to stockholders of

SAN RAMON, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2022. Revenue increased 15% year-over-year to $829.8 million. CooperVision (CVI) revenue up 6% to $553.8 million, and CooperSurgical (CSI)

SAN RAMON, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 9, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:00 PM ET.

SAN RAMON, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (“Cooper”) (NYSE: COO) announced today the publication of its 2021 Environmental, Social, and Governance (ESG) Highlights Report , sharing the Company’s progress on ESG items most important to its businesses and stakeholders,

SAN RAMON, Calif., April 28, 2022 - CooperCompanies (NYSE: COO) today announced it will release second quarter 2022 financial results on Thursday, June 2, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate

SAN RAMON, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that Cooper and Cook Medical have each received a request for additional information (“second request”) from the U.S. Federal Trade Commission (FTC) in connection with Cooper’s pending acquisition of

EssilorLuxottica and CooperCompanies initiative accelerates commercialization of innovative myopia management technologies CHARENTON-LE-PONT, France and SAN RAMON, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- EssilorLuxottica and CooperCompanies are pleased to announce the finalization of their joint

SAN RAMON, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its first quarter of fiscal year 2022, which ended January 31, 2022. Revenue increased 16% year-over-year to $787.2 million. CooperVision (CVI) revenue up 11% to $561.5 million,

SAN RAMON, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present at Oppenheimer’s 32 nd Annual Healthcare Conference on Wednesday, March 16, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual

Acquisition will enhance CooperSurgical’s international fertility footprint and medical device portfolio SAN RAMON, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business,